CAS RN: 1421373-62-7
Mutant EGFR inhibitor
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
≥98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250108
2mg / 5mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1421373-62-7
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
1421373-62-7 / N-[5-[[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino]-2-[2-(dimethylamino)ethyl-methylamino]-4-methoxyphenyl]prop-2-enamide
Standard CAS: 1421373-62-7
Multi CAS: No
Basic Information
copy
CAS
1421373-62-7 copy
Multi CAS
No copy
Molecular Formula
C27H30ClN7O2 copy
Molecular Weight
520.000000 copy
Exact Mass
519.214951 copy
SMILES
CN(C)CCN(C)C1=CC(=C(C=C1NC(=O)C=C)NC2=NC=C(C(=N2)C3=CNC4=CC=CC=C43)Cl)OC copy
InChI
InChI=1S/C27H30ClN7O2/c1-6-25(36)31-21-13-22(24(37-5)14-23(21)35(4)12-11-34(2)3)32-27-30-16-19(28)26(33-27)18-15-29-20-10-8-7-9-17(18)20/h6-10,13-16,29H,1,11-12H2,2-5H3,(H,31,36)(H,30,32,33) copy
InChIKey
SUPQPCQJBYPRPC-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
37 copy
Aromatic heavy atom count
21 copy
Fraction Csp3
0.22 copy
Rotatable bonds
10 copy
H-bond acceptors
7 copy
H-bond donors
3 copy
Molar refractivity
151.26 copy
TPSA
98.41 copy
LogP / Solubility
WLOGP
5.15 copy
MLOGP
4.57 copy
XLogP3
4.4 copy
Consensus LogP
4.71 copy
Log S (ESOL)
-6.07 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-7.54 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-8.52 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.23 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
No copy
Bioavailability score
0.56 copy
Brenk alerts
1 copy
Leadlikeness
No copy
Synthetic Accessibility
4.5 copy